Views

CrossRef citations to date

Altmetric

Original Research

Medical management, costs, and consequences of Alzheimer’s disease in Germany: an analysis of health claims data

Bernd BrüggenjürgenInstitute for Social Medicine, Epidemiology and Health Economics, Berlin, Germany, and Boston Healthcare Associates International GmbH, Berlin, GermanyCorrespondence[email protected]

Frank AndersohnInstitute for Social Medicine, Epidemiology and Health Economics, Berlin, Germany, and Frank Andersohn Consulting & Research Services, Berlin, Germany

Nadja EzzatBoston Healthcare Associates International GmbH, Berlin, Germany

Loretto LaceyJanssen Alzheimer Immunotherapy, Dublin, Ireland

Stefan WillichInstitute for Social Medicine, Epidemiology and Health Economics, Berlin, Germany

Figures & data

Table 1. Numbers and proportions of ambulatory diagnoses (ICD-10 GM) of dementia during the study period.Citation1.

Download CSV Display Table

Figure 1. Study design of propensity score matched cohort.

Figure 2. Standardized differences (Love plot, difference in percent) of diagnoses and prescriptions before and after propensity score matching (Alzheimer’s dementia).

Table 2. Characteristics of the study and control population (SD) before propensity-score matching.

Download CSV Display Table

Table 3. Annual healthcare costs in Euros (SD) before propensity-score matching.

Download CSV Display Table

Table 4. Leading diagnoses and drugs after propensity score matching.

Download CSV Display Table

Table 5. Event rates and costs in propensity-score matched cohort before and after diagnosis of dementia (POR 95% CI).

Download CSV Display Table

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Medical management, costs, and consequences of Alzheimer’s disease in Germany: an analysis of health claims data

Table 1. Numbers and proportions of ambulatory diagnoses (ICD-10 GM) of dementia during the study period.Citation1.

Table 2. Characteristics of the study and control population (SD) before propensity-score matching.

Table 3. Annual healthcare costs in Euros (SD) before propensity-score matching.

Table 4. Leading diagnoses and drugs after propensity score matching.

Table 5. Event rates and costs in propensity-score matched cohort before and after diagnosis of dementia (POR 95% CI).

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Medical management, costs, and consequences of Alzheimer’s disease in Germany: an analysis of health claims data

Figures & data

Table 1. Numbers and proportions of ambulatory diagnoses (ICD-10 GM) of dementia during the study period.Citation1.

Table 2. Characteristics of the study and control population (SD) before propensity-score matching.

Table 3. Annual healthcare costs in Euros (SD) before propensity-score matching.

Table 4. Leading diagnoses and drugs after propensity score matching.

Table 5. Event rates and costs in propensity-score matched cohort before and after diagnosis of dementia (POR 95% CI).

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date